Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kangda'an Sugar Capsule
- Development stage
- Unknown
- Lead developer
- Buchang Pharmaceuticals
- Administration
- Oral
01
Overview
**Kangda'an Sugar Capsule** is an oral Chinese health-care capsule promoted for diabetes management. Public materials from Pingchuan Pharmaceutical described the product as having been developed in 1998 and introduced to market in 2001; a 2005 distribution announcement characterized it as a health-care product rather than identifying it as an approved pharmaceutical medicine. Its specific active-ingredient composition, molecular targets, and evidence-based mechanism of action were not established in the public sources reviewed. ([diswww.mit.edu](https://diswww.mit.edu/MENELAUS.MIT.EDU/motif/924))
- Brand names
- Kangda'an Sugar Capsule
- Other names
- Kang Da Glycosuria Capsule
Beyond the preview
Go deeper on Kangda'an Sugar Capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kangda'an Sugar Capsule.